S&T Bank PA grew its stake in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 2.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 705,807 shares of the software maker’s stock after buying an additional 14,829 shares during the period. S&T Bank PA owned 0.39% of Allscripts Healthcare Solutions worth $9,006,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wesbanco Bank Inc. grew its position in shares of Allscripts Healthcare Solutions by 131.4% in the 2nd quarter. Wesbanco Bank Inc. now owns 147,587 shares of the software maker’s stock valued at $1,883,000 after buying an additional 83,807 shares during the last quarter. Thrivent Financial For Lutherans raised its stake in Allscripts Healthcare Solutions by 255.4% during the 1st quarter. Thrivent Financial For Lutherans now owns 111,780 shares of the software maker’s stock worth $1,418,000 after acquiring an additional 80,330 shares in the last quarter. Dalton Greiner Hartman Maher & Co. purchased a new stake in Allscripts Healthcare Solutions in the second quarter valued at $1,276,000. OppenheimerFunds Inc. lifted its position in Allscripts Healthcare Solutions by 9.4% in the first quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock valued at $399,000 after acquiring an additional 2,701 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its position in Allscripts Healthcare Solutions by 6.8% in the second quarter. Victory Capital Management Inc. now owns 1,627,164 shares of the software maker’s stock valued at $20,763,000 after acquiring an additional 103,395 shares during the last quarter.

In other news, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $13.52, for a total transaction of $67,600.00. Following the completion of the transaction, the executive vice president now owns 196,607 shares in the company, valued at $2,658,126.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Richard J. Poulton sold 15,000 shares of the company’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $13.56, for a total transaction of $203,400.00. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock worth $473,800 over the last quarter. 0.75% of the stock is currently owned by company insiders.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) traded up 0.14% during trading on Wednesday, reaching $14.37. 780,813 shares of the company’s stock were exchanged. The stock’s market capitalization is $2.60 billion. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $14.45. The company’s 50-day moving average is $13.43 and its 200 day moving average is $12.55.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.15 by ($0.04). Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The company had revenue of $426.10 million during the quarter, compared to analyst estimates of $424.94 million. During the same period in the prior year, the business earned $0.14 earnings per share. Allscripts Healthcare Solutions’s quarterly revenue was up 10.2% on a year-over-year basis. On average, analysts forecast that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was posted by Marea Informative and is the property of of Marea Informative. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at http://www.mareainformativa.com/allscripts-healthcare-solutions-inc-mdrx-shares-bought-by-st-bank-pa/115647/.

MDRX has been the subject of several research analyst reports. Cantor Fitzgerald upgraded shares of Allscripts Healthcare Solutions from a “neutral” rating to an “overweight” rating and set a $12.00 price objective for the company in a research note on Tuesday, August 15th. Leerink Swann lowered Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $15.00 to $13.00 in a report on Monday, June 19th. BidaskClub upgraded Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. Dougherty & Co reiterated a “buy” rating and set a $16.00 target price (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Tuesday. Finally, Zacks Investment Research raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, August 9th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $15.29.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.